Clinical Trial Update: A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women [Phase 2]

View source ↗

Summary

A Phase 2 multinational trial evaluated the effects of a 28-day oral contraceptive on hemostatic parameters in healthy women; results completed with postings in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception-related Disorders
• Hemostasis

Drugs mentioned

• Oral contraceptive (28-day regimen) studied by Teva Branded Pharmaceutical Products R&D, Inc.

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Hemostasis, Oral Contraceptive | Phase 2 | Status: COMPLETED | Results posted: 2013-11-27